PMID- 21501832 OWN - NLM STAT- MEDLINE DCOM- 20111019 LR - 20211203 IS - 1934-6069 (Electronic) IS - 1931-3128 (Linking) VI - 9 IP - 4 DP - 2011 Apr 21 TI - Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection. PG - 331-41 LID - 10.1016/j.chom.2011.03.008 [doi] AB - The protozoan parasite Leishmania alters the activity of its host cell, the macrophage. However, little is known about the effect of Leishmania infection on host protein synthesis. Here, we show that the Leishmania protease GP63 cleaves the mammalian/mechanistic target of rapamycin (mTOR), a serine/threonine kinase that regulates the translational repressor 4E-BP1. mTOR cleavage results in the inhibition of mTOR complex 1 (mTORC1) and concomitant activation of 4E-BP1 to promote Leishmania proliferation. Consistent with these results, pharmacological activation of 4E-BPs with rapamycin, results in a dramatic increase in parasite replication. In contrast, genetic deletion of 4E-BP1/2 reduces parasite load in macrophages ex vivo and decreases susceptibility to cutaneous leishmaniasis in vivo. The parasite resistant phenotype of 4E-BP1/2 double-knockout mice involves an enhanced type I IFN response. This study demonstrates that Leishmania evolved a survival mechanism by activating 4E-BPs, which serve as major targets for host translational control. CI - Copyright (c) 2011 Elsevier Inc. All rights reserved. FAU - Jaramillo, Maritza AU - Jaramillo M AD - Department of Biochemistry and Goodman Cancer Center, McGill University, Montreal, Quebec, Canada. FAU - Gomez, Maria Adelaida AU - Gomez MA FAU - Larsson, Ola AU - Larsson O FAU - Shio, Marina Tiemi AU - Shio MT FAU - Topisirovic, Ivan AU - Topisirovic I FAU - Contreras, Irazu AU - Contreras I FAU - Luxenburg, Randi AU - Luxenburg R FAU - Rosenfeld, Amy AU - Rosenfeld A FAU - Colina, Rodney AU - Colina R FAU - McMaster, Robert W AU - McMaster RW FAU - Olivier, Martin AU - Olivier M FAU - Costa-Mattioli, Mauro AU - Costa-Mattioli M FAU - Sonenberg, Nahum AU - Sonenberg N LA - eng GR - Canadian Institutes of Health Research/Canada PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Cell Host Microbe JT - Cell host & microbe JID - 101302316 RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (Carrier Proteins) RN - 0 (Cell Cycle Proteins) RN - 0 (Eif4ebp1 protein, mouse) RN - 0 (Eukaryotic Initiation Factors) RN - 0 (Multiprotein Complexes) RN - 0 (Phosphoproteins) RN - 0 (Proteins) RN - EC 2.7.1.1 (mTOR protein, mouse) RN - EC 2.7.11.1 (Mechanistic Target of Rapamycin Complex 1) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 3.4.24.- (Metalloendopeptidases) RN - EC 3.4.24.- (glycoprotein gp63, Leishmania) RN - W36ZG6FT64 (Sirolimus) SB - IM CIN - Cell Host Microbe. 2011 Apr 21;9(4):257-9. PMID: 21501824 MH - Adaptor Proteins, Signal Transducing MH - Animals MH - Carrier Proteins/genetics/metabolism MH - Cell Cycle Proteins MH - Cell Line MH - Eukaryotic Initiation Factors MH - *Host-Parasite Interactions MH - Leishmania major/*physiology MH - Leishmaniasis, Cutaneous/*metabolism/parasitology MH - Macrophages/*metabolism/parasitology MH - Mechanistic Target of Rapamycin Complex 1 MH - Metalloendopeptidases/metabolism MH - Mice MH - Multiprotein Complexes MH - Phosphoproteins/genetics/metabolism MH - Polymerase Chain Reaction MH - Protein Biosynthesis MH - Proteins/metabolism MH - Sequence Deletion MH - Signal Transduction/genetics MH - Sirolimus/pharmacology MH - TOR Serine-Threonine Kinases/*metabolism EDAT- 2011/04/20 06:00 MHDA- 2011/10/20 06:00 CRDT- 2011/04/20 06:00 PHST- 2009/12/05 00:00 [received] PHST- 2010/10/01 00:00 [revised] PHST- 2011/03/04 00:00 [accepted] PHST- 2011/04/20 06:00 [entrez] PHST- 2011/04/20 06:00 [pubmed] PHST- 2011/10/20 06:00 [medline] AID - S1931-3128(11)00095-3 [pii] AID - 10.1016/j.chom.2011.03.008 [doi] PST - ppublish SO - Cell Host Microbe. 2011 Apr 21;9(4):331-41. doi: 10.1016/j.chom.2011.03.008.